Are glycopeptide-resistant enterococci in animals a threat to human beings?

Lancet

Volumn 349, Issue 9057, 1997, Pages 997-998

  Das, Ira ^a   Fraise, Adam ^b   Wise, Richard ^b  

^a CITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AVOPARCIN; CEFUROXIME; GLYCOPEPTIDE; METRONIDAZOLE; TEICOPLANIN; VANCOMYCIN;

ADULT; ANIMAL FOOD; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CHICKEN; DISEASE TRANSMISSION; ENTEROCOCCUS; FEMUR FRACTURE; GRAM NEGATIVE INFECTION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; WOUND INFECTION;

EID: 0030997555     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62894-2     Document Type: Article

References (5)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in microbial etiology of nosocomial infection. Am J Med. 1991; 91 (suppl 3B): 72s-75s.
2. Bates J, Jordans JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-16.
3. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995; 125: 165-72.
4. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 24-27.
5. Mudd AJ. Is it time to ban all antibiotics as animal growth-promoting agents? Lancet 1996; 348: 1454-55.